GLP-1 agonists: Uses, common brands, and safety info
In this article:
Key takeaways
The United States spends billions on the management of chronic diseases. Two of the most prevalent and expensive conditions in the United States are Type 2 diabetes mellitus and obesity.
Recent pharmaceutical advancements have produced a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which have given us a new way to combat diabetes and obesity.
GLP-1 receptor agonists can be combined with other diabetic treatments to provide further control of high blood sugar levels by enhancing insulin action and combating hunger.
Some GLP-1 agonists are approved as a component of a comprehensive weight loss plan for obese patients. This class of drugs provides a medication option for obese adults that may produce a substantial decrease in body weight and improve health outcomes.
Save big on your prescriptions
with the free SingleCare app.
4.8 average rating
List of GLP-1 agonists
| Drug name | See SingleCare price |
|---|---|
| Ozempic |  |
| Wegovy | |
| Trulicity | |
| Saxenda | |
| Liraglutide | |
| Victoza | |
| Liraglutide - Weight Management | |
| Rybelsus | |
| Mounjaro | |
| Zepbound | |
| Foundayo | |
Subscribe to our savings newsletter
Health education, drug info, wellness & more
By clicking 'Subscribe', I agree to SingleCare's Terms & Conditions.
